"Shares of Tylenol maker Kenvue bounced back sharply at the opening bell Tuesday, a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines, and autism. "Don't take Tylenol," Trump instructed pregnant women around a dozen times during the White House news conference Monday, also urging mothers not to give their infants the drug, known by the generic name acetaminophen in the U.S. or paracetamol in most other countries."
"The announcement, which appeared to rely on existing studies rather than significant new research, arrives as Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine skeptic, advances the Make America Healthy Again movement that has focused on what it sees as potential causes of autism. Kenvue disputed any link between the drug and autism this week and warned that if pregnant mothers don't use Tylenol when in need, they could face a dangerous choice between suffering fevers or using riskier alternatives."
Kenvue's Tylenol shares fell 7.5% on Monday after claims linking the drug to autism were promoted, then rebounded more than 6% at Tuesday's open. The claims advised pregnant women and mothers to avoid acetaminophen and relied on existing studies rather than significant new research. A vaccine skeptic associated with the Make America Healthy Again movement has emphasized possible autism causes. Kenvue denied any link between Tylenol and autism and warned that avoiding the drug could force pregnant mothers to choose between fevers or potentially riskier alternatives. The company, spun off from Johnson & Johnson in 2023, has faced hundreds of lawsuits over the product but most have been dismissed, and analysts see limited new lawsuit risk while noting potential harm to consumption from negative headlines.
Read at Fast Company
Unable to calculate read time
Collection
[
|
...
]